Arkolith/Insider Trading/ROIV/Form 4

Epperly Melissa B,

DirectorRoivant Sciences Ltd. (ROIV) · full profile →Form 4 · filed Jul 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$610K
Net Open-Market Flow
-$610K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 29, 2026Option exercise(M)18K$4.46$79K34K
Jun 29, 2026Sell(S)15K$34.32$515K19K
Jun 29, 2026Sell(S)3K$34.71$95K16K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 29, 2026Option exercise(M)18K—$0169K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001807359-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML